实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
13期
2034-2037
,共4页
江洪%易春峰%李元红%胡笑容%徐昌武
江洪%易春峰%李元紅%鬍笑容%徐昌武
강홍%역춘봉%리원홍%호소용%서창무
心肌缺血%丁酸钠%再灌注%高迁移率族蛋白1
心肌缺血%丁痠鈉%再灌註%高遷移率族蛋白1
심기결혈%정산납%재관주%고천이솔족단백1
Myocardial ischemia%Sodium butyrate%Reperfusion%High mobility group box 1 protein
目的:探讨丁酸钠预处理对大鼠缺血/再灌注(I/ R)损伤的影响。方法:大鼠缺血前30 min用丁酸钠(100或300 mg/kg,腹腔注射)处理,结扎冠脉前降支缺血30 min 再灌注4 h;检测乳酸脱氢酶(LDH)、肌酸激酶(CK)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)、丙二醛(MDA)和超氧化物歧化酶(SOD);应用2,3,5-氯化三苯基四氮(TTC)法检测心梗面积;蛋白免疫印迹法检测高迁移率族蛋白1(HMGB1)表达。结果:再灌注4 h后,相对于对照组,丁酸钠(300 mg/kg)预处理显著减少心梗面积;降低LDH 和CK 的表达水平(P <0.05);抑制 MDA 含量增加,抑制 SOD 含量的减少(P <0.05);也明显抑制 I/R 所诱导的TNF-α、IL-6和HMGB1的表达(均P <0.05)。结论:丁酸钠预处理可通过减轻炎症反应进而减轻心肌 I/R损伤。
目的:探討丁痠鈉預處理對大鼠缺血/再灌註(I/ R)損傷的影響。方法:大鼠缺血前30 min用丁痠鈉(100或300 mg/kg,腹腔註射)處理,結扎冠脈前降支缺血30 min 再灌註4 h;檢測乳痠脫氫酶(LDH)、肌痠激酶(CK)、腫瘤壞死因子-α(TNF-α)和白細胞介素-6(IL-6)、丙二醛(MDA)和超氧化物歧化酶(SOD);應用2,3,5-氯化三苯基四氮(TTC)法檢測心梗麵積;蛋白免疫印跡法檢測高遷移率族蛋白1(HMGB1)錶達。結果:再灌註4 h後,相對于對照組,丁痠鈉(300 mg/kg)預處理顯著減少心梗麵積;降低LDH 和CK 的錶達水平(P <0.05);抑製 MDA 含量增加,抑製 SOD 含量的減少(P <0.05);也明顯抑製 I/R 所誘導的TNF-α、IL-6和HMGB1的錶達(均P <0.05)。結論:丁痠鈉預處理可通過減輕炎癥反應進而減輕心肌 I/R損傷。
목적:탐토정산납예처리대대서결혈/재관주(I/ R)손상적영향。방법:대서결혈전30 min용정산납(100혹300 mg/kg,복강주사)처리,결찰관맥전강지결혈30 min 재관주4 h;검측유산탈경매(LDH)、기산격매(CK)、종류배사인자-α(TNF-α)화백세포개소-6(IL-6)、병이철(MDA)화초양화물기화매(SOD);응용2,3,5-록화삼분기사담(TTC)법검측심경면적;단백면역인적법검측고천이솔족단백1(HMGB1)표체。결과:재관주4 h후,상대우대조조,정산납(300 mg/kg)예처리현저감소심경면적;강저LDH 화CK 적표체수평(P <0.05);억제 MDA 함량증가,억제 SOD 함량적감소(P <0.05);야명현억제 I/R 소유도적TNF-α、IL-6화HMGB1적표체(균P <0.05)。결론:정산납예처리가통과감경염증반응진이감경심기 I/R손상。
Objective To investigate the effect of preconditioning with sodium butyrate on myocardial I/R injury. Methods Anesthetized rats were treated with sodium butyrate (100 or 300 mg/kg, i.p.) 30 mins before ischemia, and then subjected to ischemia for 30 min followed by reperfusion for 4 h. LDH, CK, TNF-α, IL-6, HMGB1, infarct size, MDA and SOD activity were measured. The infracted size was tested by TTC assay; The expression of HMGB1 was observed by western blot. Results After 4 h reperfusion, pretreatment of sodium butyrate (300 mg/kg) could significantly reduce the infarct size and the levels of LDH and CK (P<0.05)comparing to the control group; inhibit the increase of the MDA level and the decrease of the SOD level(P<0.05), also inhibit the expression of TNF-α, IL-6 and HMGB1 (all P < 0.05) induced by I/R. Conclusion Preconditioning of sodium butyrate can attenuate myocardial I/R injury by inhibiting inflammation response.